MARC record from Internet Archive

LEADER: 02927cam 2200457 i 4500
001 9925308136301661
005 20180125142751.0
007 ta
008 170130t20172017nyua b 001 0 eng c
010 $a 2017004139
019 $a969415138$a990961694
020 $a9781107168480$qhardcover
020 $a1107168481$qhardcover
024 8 $a13382979
035 $a99976086964
035 $a(OCoLC)971615468$z(OCoLC)969415138$z(OCoLC)990961694
035 $a(OCoLC)ocn971615468
040 $aDNLM/DLC$beng$erda$cDLC$dNLM$dOCLCO$dBDX$dOCLCQ$dBTCTA$dYDX$dYDX$dOCLCO$dOCLCF$dGWL$dOCLCO$dGUA$dCHVBK$dW2U$dOCL$dOCLCO$dOCLCA$dONS
042 $apcc
043 $an-us---
050 04 $aRA401.A3$bD78 2017
082 00 $a338.4/76151$223
100 1 $aFeldman, Robin,$eauthor.
245 10 $aDrug wars :$bhow big pharma raises prices and keeps generics off the market /$cRobin Feldman, Evan Frondorf.
264 1 $aNew York, NY :$bCambridge University Press,$c2017.
264 4 $c℗♭2017
300 $axii, 151 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aBig scandals, higher prices -- The winding road to generic entry -- "Generation 1.0" : the rise and fall of traditional pay-for-delay -- "Generation 2.0" : complicating pay-for-delay -- "Generation 3.0" : new tactics for active obstruction of generics -- "Generation 3.0" : continued obstruction of regulatory pathways -- Empirical evidence of a citizen's pathway gone astray -- A call for systematic reform.
520 $a"While the shockingly high prices of prescription drugs continue to dominate the news, the strategies used by pharmaceutical companies to prevent generic competition are poorly understood, even by the lawmakers responsible for regulating them. In this groundbreaking work, Robin Feldman and Evan Frondorf illuminate the inner workings of the pharmaceutical market and show how drug companies twist health policy to achieve goals contrary to the public interest. In highly engaging prose, they offer specific examples of how generic competition has been stifled for years, with costs climbing into the billions and everyday consumers paying the price. Drug Wars is a guide to the current landscape, a roadmap for reform, and a warning of what is to come. It should be read by policymakers, academics, patients, and anyone else concerned with the soaring costs of prescription drugs"--Provided by publisher.
650 0 $aDrugs$xPrices$zUnited States.
650 0 $aDrugs$xLaw and legislation$zUnited States.
650 0 $aPharmaceutical policy$zUnited States.
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aGeneric drugs$zUnited States.
700 1 $aFrondorf, Evan,$eauthor.
947 $hCIRCSTACKS$r31786103115272
980 $a99976086964